SRZN - Surrozen, Inc./DE
27.74
0.340 1.226%
Share volume: 101,232
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$27.40
0.34
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-12-2024 | 11-06-2024 | 05-09-2025 | 11-07-2025 | |
| Assets | ||||||
| Total Assets | 36.716 M | 45.071 M | 47.998 M | 114.829 M | 94.046 M | |
| Current Assets | 32.015 M | 41.637 M | 45.286 M | 106.011 M | 85.860 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 27.290 M | 37.765 M | 31.012 M | 101.645 M | 81.335 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.584 M | 1.198 M | 856.000 K | 295.000 K | 139.000 K | |
| Other Assets | 3.117 M | 2.236 M | 1.856 M | 8.523 M | 8.047 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 36.716 M | 45.071 M | 47.998 M | 114.829 M | 94.046 M | |
| Total liabilities | 6.580 M | 39.009 M | 42.331 M | 109.155 M | 117.561 M | |
| Total current liabilities | 6.179 M | 5.983 M | 6.120 M | 10.582 M | 6.528 M | |
| Accounts Payable | 131.000 K | 173.000 K | 276.000 K | 302.000 K | 538.000 K | |
| Other liabilities | 401.000 K | 33.026 M | 36.211 M | 98.573 M | 111.033 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 401.000 K | 33.026 M | 36.211 M | 98.573 M | 111.033 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 30.136 M | 6.062 M | 5.667 M | 5.674 M | -23.515 M | |
| Common stock | 260.661 M | 261.848 M | 262.887 M | 317.903 M | 320.611 M | |
| Retained earnings | -230.525 M | -255.786 M | -257.220 M | -312.229 M | -344.126 M |